...
首页> 外文期刊>Molecular & cellular proteomics: MCP >Proteome Profiling Outperforms Transcriptome Profiling for Coexpression Based Gene Function Prediction
【24h】

Proteome Profiling Outperforms Transcriptome Profiling for Coexpression Based Gene Function Prediction

机译:蛋白质组分析优于基于共表达的基因功能预测的转录物分析

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Coexpression of mRNAs under multiple conditions is commonly used to infer cofunctionality of their gene products despite well-known limitations of this "guilt-by-association" (GBA) approach. Recent advancements in mass spectrometry-based proteomic technologies have enabled global expression profiling at the protein level; however, whether proteome profiling data can outperform transcriptome profiling data for coexpression based gene function prediction has not been systematically investigated. Here, we address this question by constructing and analyzing mRNA and protein coexpression networks for three cancer types with matched mRNA and protein profiling data from The Cancer Genome Atlas (TCGA) and the Clinical Proteomic Tumor Analysis Consortium (CPTAC). Our analyses revealed a marked difference in wiring between the mRNA and protein coexpression networks. Whereas protein coexpression was driven primarily by functional similarity between coexpressed genes, mRNA coexpression was driven by both cofunction and chromosomal colocalization of the genes. Functionally coherent mRNA modules were more likely to have their edges preserved in corresponding protein networks than functionally incoherent mRNA modules. Proteomic data strengthened the link between gene expression and function for at least 75% of Gene Ontology (GO) biological processes and 90% of KEGG pathways. A web application Gene2Net (http://cptac.gene2net.org) developed based on the three protein coexpression networks revealed novel gene-function relationships, such as linking ERBB2 (HER2) to lipid biosynthetic process in breast cancer, identifying PLG as a new gene involved in complement activation, and identifying AEBP1 as a new epithelial-mesenchymal transition (EMT) marker. Our results demonstrate that proteome profiling outperforms transcriptome profiling for coexpression based gene function prediction. Proteomics should be integrated if not preferred in gene function and human disease studies.
机译:尽管这种“逐个关联”(GBA)方法的众所周知,但MRNA在多种条件下MRNA的共表达通常用于推断其基因产品的焦结性。基于质谱的蛋白质组学技术的最新进展使全球表达谱系能够在蛋白质水平进行;然而,蛋白质组分析数据是否可以优于基于基于共表达的基因功能预测的转录组分析数据。在这里,我们通过从癌症基因组Atlas(TCGA)和临床蛋白质组学肿瘤分析联盟(CPTAC)的癌症基因组(TCGA)和临床蛋白质组学肿瘤分析联盟(CPTAC)构建和分析三种癌症类型的mRNA和蛋白质共抑制网络来解决这个问题。我们的分析显示了mRNA和蛋白质共表达网络之间的布线的显着差异。蛋白质共表达主要通过共表达基因之间的功能相似性,通过COF功能和基因的染色体分层驱动MRNA共表达。功能相干的mRNA模块更可能在相应的蛋白质网络中保留它们的边缘而不是功能不相干的mRNA模块。蛋白质组学数据加强了基因表达与至少75%的基因本体学(GO)生物学方法和90%的Kegg途径的联系。基于三种蛋白质共表达网络开发的Web应用程序Gene2Net(http://cptac.gene2net.org)揭示了新的基因功能关系,例如将erbb2(her2)链接到乳腺癌中的脂质生物合成过程,将PLG识别为新的参与补体激活的基因,并将AEBP1鉴定为新的上皮 - 间充质转换(EMT)标记。我们的结果表明,用于基于共表达的基因功能预测的蛋白质组分析优于转录组分析。如果基因函数和人类疾病研究中不优选,则应集成蛋白质组学。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号